Lithuania has registered 126 new coronavirus infections and three deaths from Covid-19 over the past 24 hours, the country's statistics office said on Wednesday morning.
There have been 9,185 molecular (PCR) tests and 4,693 antigen tests performed in the last 24 hours.
Lithuania's 14-day coronavirus infection rate currently stands at 102.5 cases per 100,000 people, and the share of positive tests has been 1.1 percent over the past seven days.
Overall, 278,072 people have tested positive for Covid-19 in Lithuania since the start of the pandemic.
A total of 4,352 people have died from Covid-19 in Lithuania so far. The overall number of deaths directly or indirectly related to the coronavirus has reached 8,822.
Over the past 24 hours, 8,083 people have received the first shot of the coronavirus vaccine and 16,066 have received the second jab.
As of Wednesday morning, 1,183,917 people in Lithuania have received at least one shot of the vaccine, or 42.4 percent of the population, and 772,958 have received two jabs.
Prime minister gets second jab
Lithuanian Prime Minister Ingrida Šimonytė received her second dose of the AstraZeneca vaccine on Wednesday morning.
The prime minister was vaccinated at the Litexpo vaccination centre in Vilnius.
Meanwhile, President Gitanas Nausėda received his second jab a little earlier, which was not mentioned on his agenda.
“The president has already received his second dose. The first dose was administered publicly to encourage people to get vaccinated. And the administration of the second dose was adapted to the head of state's schedule and the family doctor's recommendation,” Dovile Salkuvienė, a spokeswoman for the president, told BNS.
She said there was no public need to put the vaccination on the president's agenda.
Aistė Šukšta, spokeswoman for Health Minister Arūnas Dulkys, has told BNS the minister will get the second vaccine jab later this week when he returns from a working trip.
Lithuania's leaders and the health minister received the first shots of the AstraZeneca vaccine on March 22 to promote public trust in this vaccine.
Newsletter
Every Friday morning.
